Rerefined model

PDB 2XMY|dpdb_c1lgt67t

Rerefined model

Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents

Program
PHENIX 2.0_5824
Model type
Multiconformer
Purpose
Refinement
Atoms
2,630
Residues
295
Protein chains
1
Alternate-location fraction
2.03%
Ligand
CDK

Evaluations

R-work
0.215
R-free
0.261
Clashscore
9.0

Macromolecules

The same in every model of this entry.

Entity 1
MoleculeChainsLengthOrganismUniProtDetails
CELL DIVISION PROTEIN KINASE 2298—

Data

L0 Raw
L1 Processed
L2 Models
L3 Evaluations